| Unaudited Quarterly Results for the 3rd quarter & period ended 31st December,
2004 |
| Notes: |
| 1. |
The
above unaudited results which are subjected to limited review by
the Auditors of the Company, were reviewed by the Audit
Committee and have been taken on record by the Board at its
meeting held on 15.01.2005. |
|
2. |
The Company
has provided higher rate depreciation on assets of newly
acquired Unit at Bhiwadi, based on useful life of asset as
against the rates prescribed under Schedule XIV of Companies
Act, 1956.. |
| 3. |
Exports constitute Rs.1522.9 millions (Rs.1645.4 millions)
of the sales for the quarter. |
| 4. |
The
Company's operations fall within a single primary business
segment viz 'Pharmaceutical Products'. |
| 5. |
Investor complaints pending at the beginning of the
quarter: Nil, received: 120, resolved: 120 and lying
unresolved at the end of the quarter: Nil. |
| 6. |
Figures
for the previous periods have been rearranged/regrouped wherever
necessary. |
|